Clinical Trial Update: Repurposing Itraconazole as an Adjuvant Therapy in Treatment of Patients With Acute Myeloid Leukemia: Is it a Hopeful Avenue for Enhancing Treatment Options? [Phase 2]

View source ↗

Summary

Phase 2 clinical trial is evaluating repurposed itraconazole as an adjuvant therapy for acute myeloid leukemia; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Itraconazole (Itraconazole)

Snippet

Sponsor: Mansoura University | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: NOT_YET_RECRUITING